Cargando…
Sphingosylphosphorylcholine blocks ovariectomy‐induced bone loss by suppressing Ca(2+)/calmodulin‐mediated osteoclast differentiation
Osteoporosis is a disease in which bone mineral density decreases due to abnormal activity of osteoclasts, and is commonly found in post‐menopausal women who have decreased levels of female hormones. Sphingosylphosphorylcholine (SPC) is an important biological lipid that can be converted to sphingos...
Autores principales: | Lee, Ha Young, Cho, Kwang Min, Kim, Min Kyung, Lee, Mingyu, Kim, Hun, Choi, Cheol Yong, Kim, Kyeong Kyu, Park, Joon Seong, Kim, Hong‐Hee, Bae, Yoe‐Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810965/ https://www.ncbi.nlm.nih.gov/pubmed/33230972 http://dx.doi.org/10.1111/jcmm.16101 |
Ejemplares similares
-
Isovaleric acid ameliorates ovariectomy‐induced osteoporosis by inhibiting osteoclast differentiation
por: Cho, Kwang Min, et al.
Publicado: (2021) -
Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
por: Park, Byunghyun, et al.
Publicado: (2023) -
Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
por: Jeong, Hyo-Soon, et al.
Publicado: (2011) -
FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2
por: Park, Min Young, et al.
Publicado: (2017) -
Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment
por: Park, Mi Kyung, et al.
Publicado: (2019)